Ankit Dhiman Selected Research

myrtol

1/2022

Celecoxib and Myrtol: A Novel Therapy for Recurrent Appendiceal Mucinous Neoplasms With Extensive Peritoneal Dissemination.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ankit Dhiman Research Topics

Disease

3	Neoplasms (Cancer) 01/2022 - 11/2021
2	Neoplasm Metastasis (Metastasis) 04/2022 - 01/2022
2	Adenocarcinoma 04/2022 - 01/2022
1	Peritoneal Diseases 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Neoplasms, Cystic, Mucinous, and Serous 01/2022

Drug/Important Bio-Agent (IBA)

2	Circulating Tumor DNAIBA 04/2022 - 01/2022
1	Nucleic AcidsIBA 01/2022
1	DeoxyriboseIBA 01/2022
1	myrtolIBA 01/2022
1	Celecoxib (Celebrex)FDA Link 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022

Therapy/Procedure

3	Therapeutics 04/2022 - 01/2022
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2022
1	Induction Chemotherapy 01/2022
1	Metastasectomy 01/2022
1	Hyperthermic Intraperitoneal Chemotherapy 11/2021
1	Cytoreduction Surgical Procedures 11/2021